LEADER 01873nam  2200349   450 
001 9910683390103321
005 20230705025954.0
010   $a3-0365-6704-6
035   $a(CKB)5700000000354328
035   $a(NjHacI)995700000000354328
035   $a(EXLCZ)995700000000354328
100   $a20230705d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHuman Papillomavirus and Head and Neck Cancer /$fHeather Walline, editor
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (268 pages)
311   $a3-0365-6705-4 
330   $aIn the study of head and neck squamous cell carcinoma (HNSCC), we know that virally induced malignancies behave differently than those generated through other carcinogenic mechanisms. This paradigm extends into differences in tumor growth, treatment response and resistance, as well as invasion and metastasis. The inability to correctly diagnose and appropriately treat HNSCC at early stages has contributed to reduced survival for HNSCC patients, particularly those with HPV-negative disease. The examination of the molecular differences between HPV-positive and HPV-negative HNSCC will provide support for early diagnostic markers and guide appropriate treatment selection to improve patient care and survival.This Special Issue highlights current research efforts to understand the evolving contribution of human papillomavirus in HNSCC.
606   $aPapillomavirus diseases
615  0$aPapillomavirus diseases.
676   $a616.911
702   $aWalline$b Heather
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910683390103321
996   $aHuman Papillomavirus and Head and Neck Cancer$93085008
997   $aUNINA